SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
CVTX - CV Therapeutics, Inc.
An SI Board Since January 1999
Posts SubjectMarks Bans
411 31 0
Emcee:  Todd N. Weisrock Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
361I love this CYA part: >>Several risks could drive the stock to materiallyC.Carlos-12/26/2008
360Citi: CV Therapeutics Inc (CVTX) mopgcw-12/13/2008
359The labeling is now first line, but I believe the reality is that doctors will uBiomaven-12/7/2008
358Why do you say it's still not first line? It seems to be first line to me. C.Carlos-12/7/2008
357>> Well it's still not first line << Sorry.... been very busyscaram(o)uche-11/13/2008
356>>new-onset patients who choose ranexa Well it's still not first lineBiomaven-11/11/2008
355Well..... the "one less pill" argument is interesting. If cvtx werscaram(o)uche-11/11/2008
354I don't suppose CVTX is working on some kind of extended release formulationtuck-11/11/2008
353More from Merrill. Looks like they caught some flak. >>Why we think new ltom pope-11/11/2008
352Thanks to all who have posted the the latest analyst thinking. The crux line oftuck-11/7/2008
351Thanks for sharing this. mopgcw-11/7/2008
350j. birchenough, now Barclays, 11/6/08 CV Therapeutics (CVTX - US$ 9.70) 1-Overwsoftware salesperson-11/7/2008
349>> a new team << Ah, OK. Never mind. :-)scaram(o)uche-11/7/2008
348All of those guys who haven't been able to take Cialis! OTOH, there will bescaram(o)uche-11/7/2008
347Seems to be a new team, run by Thomas Chiu, with NYC area code phone numbers.tom pope-11/7/2008
346Guffaw.... I was about to post that Citi is like ML.... NEVER correct, a grescaram(o)uche-11/7/2008
345Merrill - underperform. Label update essentially as expected Ranexa continues ttom pope-11/7/2008
344Looks to me like citi is bending over backwards to find reasons for the downgradfred hayes-11/7/2008
343Citi: November 2008 - 9 pages CV Therapeutics Inc (CVTX) Change in New Label Mmopgcw-11/7/2008
342My first basic question...... At market cap of 500m, why would ANYONE downgradescaram(o)uche-11/7/2008
341Very frustrating, trying to grab hold of what is happening to this sucker today.scaram(o)uche-11/7/2008
340and looks like no one really cares in this market...so with the expansion here, mopgcw-11/6/2008
339FDA Approves Ranexa(R) for First Line Anti Anginal Use and Adds New Claims for Rmopgcw-11/6/2008
338CV Therapeutics Reports 2008 Third Quarter Financial Results Thursday November 6mopgcw-11/6/2008
337Commercial Launch of Lexiscan(TM) (Regadenoson) Injection Triggers $10 Million Mmopgcw-6/24/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News